奇点医疗：创始人兼首席科学家何晓顺入选全球顶尖2%科学家榜单

Group 1 - Stanford University and Elsevier published the 2025 "Top 2% Global Scientists" list, recognizing the top 2% of scholars from nearly 7 million researchers worldwide [1] - Professor He Xiaoshun, Director of the Organ Transplant Center at Sun Yat-sen University First Affiliated Hospital, was honored on this list and is also the founder and chief scientist of Singularity Medical Technology [2] Group 2 - Professor He Xiaoshun is a pioneer in organ medicine, having performed the world's first non-ischemic liver transplant in 2017 and introduced the concept of "organ medicine" in 2019 [3] - The "Domino-Extracorporeal Liver Support Therapy" developed by his team provides new hope for critically ill patients who cannot undergo transplantation [3] - The "extracorporeal liver" technology allows for the maintenance of non-transplantable but functional livers, providing essential liver function support to patients in need [3] Group 3 - Singularity Medical, established in May 2020, focuses on organ medicine research and development, with a pipeline covering organ transplantation, donation, isolation treatment, and new drug development [4] - The company has achieved significant milestones, including the world's first vascular intervention for liver cancer isolation treatment and the revival of a pig brain after 50 minutes of death [4] - The company has a strong R&D team, with 51% of its workforce dedicated to research, and has filed 61 patents, with 44 granted [4] Group 4 - Singularity Medical's first innovative medical device, the "Liver Perfusion System," has entered the special review process by the National Medical Products Administration, with full case enrollment expected by October 2025 and registration anticipated by 2027 [4] - Another core product, the "Donor Perfusion System," received approval for special review in June 2025, with efforts underway to expedite clinical trials [4]